Rancak Media – , JAKARTA — Shares of PT Sentul City Tbk. (BKSL) have recorded a significant rally amidst the ongoing development of Biotown, an ambitious integrated area envisioned to become Indonesia’s first health city. This strategic project has captivated investor attention, driving robust performance for the property issuer.
According to data from the Indonesia Stock Exchange (IDX), BKSL’s shares surged by 25.35% over the past week, closing at Rp178 as of 2:25 PM WIB during trading on Thursday, December 4, 2025. This impressive short-term gain is part of a broader upward trend.
Zooming out further, BKSL shares have climbed an impressive 63.30% in the last six months and soared by a remarkable 150.70% since the beginning of the year (year-to-date/YtD). Such rapid appreciation naturally drew scrutiny from market regulators.
The Indonesia Stock Exchange, via letter number S-13607/BEI.PP1/12-2025 issued on December 3, 2025, formally requested an explanation from Sentul City’s management regarding the volatility of the company’s stock transactions. This inquiry is standard practice when a stock experiences unusual price movements.
In response, Tjetje Muljanto, Director of Sentul City, affirmed that there is no material information or facts that could significantly influence the company’s share value or investment decisions. He further clarified, “The company has no plans to undertake corporate actions in the near future that would impact the listing of the company’s shares on the Exchange,” in an official information disclosure today.
Previously, BKSL had informed the public about its plans to develop Biotown, an integrated complex poised to become Indonesia’s pioneering health city. This groundbreaking project is a cornerstone of Sentul City’s long-term vision, aiming to transform the landscape of healthcare infrastructure in the country.
: Mirae Asset Sekuritas Proyeksikan IHSG Sentuh Level 10.500 pada 2026
Hiramsyah Sambudhy Thaib, President Director of Sentul City, elaborated that Biotown is designed as a comprehensive health ecosystem. It will be built upon five core pillars: medical services, care, pharmaceutical, science, and devices. This holistic approach underscores the company’s commitment to supporting the national development agenda, aligning perfectly with key government priorities.
Moreover, the concept and strategic focus of this integrated health area are in harmony with four priority program sectors of the government: property and industry (specifically smart-green industry), healthcare, digital infrastructure, and renewable energy. This strategic alignment positions Biotown as a project of national importance, attracting potential support and incentives.
“In line with these objectives, Biotown is also being proposed as a Special Economic Zone [SEZ],” Hiramsyah revealed to Bisnis on Wednesday, November 15, 2025. This designation would provide a significant boost to the project’s development and operational framework, offering various economic advantages.
Hiramsyah explained that the SEZ proposal aims to ensure Biotown delivers a greater impact on economic growth while simultaneously enhancing the competitiveness of Indonesia’s national health industry. This strategic move is expected to attract investment and foster innovation within the sector.
“Currently, the company is formulating Biotown’s work plan and business plan in collaboration with international consultants from China, alongside preparing the necessary documentation for the SEZ status application,” he added, indicating the advanced stage of planning and execution.
In terms of financial performance, BKSL reported a significant increase in revenue, reaching Rp836.97 billion for the January-September 2025 period. This represents a robust 96.28% growth compared to the same period last year. The surge in revenue translated directly into stronger profitability.
Correspondingly, BKSL’s net profit for the period also jumped by an impressive 186.22% year-on-year (YoY), rising from Rp25.9 billion to Rp74.15 billion. These strong financial results underscore the company’s operational efficiency and positive trajectory amidst its ambitious development plans.
Sentul City Tbk. – TradingView
Disclaimer: This news article is not intended as an invitation to buy or sell shares. Investment decisions are solely at the discretion of the reader. Bisnis.com is not responsible for any losses or gains arising from the reader’s investment decisions.
Summary
PT Sentul City Tbk. (BKSL) shares have seen a significant rally, driven by the ongoing development of its ambitious Biotown project. This surge prompted an inquiry from the Indonesia Stock Exchange, to which Sentul City’s management affirmed no material information or imminent corporate actions influenced the share value. Investors are notably captivated by Biotown, envisioned as Indonesia’s pioneering integrated health city.
Biotown is planned as a comprehensive health ecosystem with five core pillars, strategically aligning with government priorities and proposed as a Special Economic Zone. This designation aims to boost economic growth and national health industry competitiveness, with planning underway in collaboration with international consultants for the SEZ application. Supporting these efforts, BKSL reported strong financial results for Jan-Sep 2025, showing significant growth in both revenue and net profit.
